Keywords: Eli Lilly, ImClone, Sanofi-Aventis, Appointments

Lilly names former Genentech exec as VP oncology research; Sanofi-Aventis names SDSAC chairman

Article | 11 March 2011

Print This

US drug major Eli Lilly (NYSE: LLY) has recruited former Genentech executive Greg Plowman to lead its oncology research efforts ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in